These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9794154)

  • 1. Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation.
    Lucas D; Farez C; Bardou LG; Vaisse J; Attali JR; Valensi P
    Fundam Clin Pharmacol; 1998; 12(5):553-8. PubMed ID: 9794154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
    Gebhardt AC; Lucas D; Ménez JF; Seitz HK
    Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher chlorzoxazone clearance in obese children compared with nonobese peers.
    Gade C; Dalhoff K; Petersen TS; Riis T; Schmeltz C; Chabanova E; Christensen HR; Mikus G; Burhenne J; Holm JC; Holst H
    Br J Clin Pharmacol; 2018 Aug; 84(8):1738-1747. PubMed ID: 29618168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype.
    Carrière V; Berthou F; Baird S; Belloc C; Beaune P; de Waziers I
    Pharmacogenetics; 1996 Jun; 6(3):203-11. PubMed ID: 8807659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.
    Lucas D; Ferrara R; Gonzalez E; Bodenez P; Albores A; Manno M; Berthou F
    Pharmacogenetics; 1999 Jun; 9(3):377-88. PubMed ID: 10471070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.
    Raucy JL; Schultz ED; Wester MR; Arora S; Johnston DE; Omdahl JL; Carpenter SP
    Drug Metab Dispos; 1997 Dec; 25(12):1429-35. PubMed ID: 9394034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.
    Varela NM; Quiñones LA; Orellana M; Poniachik J; Csendes A; Smok G; Rodrigo R; Cáceres DD; Videla LA
    Biol Res; 2008; 41(1):81-92. PubMed ID: 18769766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
    Yamamura Y; Koyama N; Umehara K
    Xenobiotica; 2015 Apr; 45(4):353-60. PubMed ID: 25815637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
    Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of CYP2E1 activity in diabetic rat model].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone.
    Carriere V; Goasduff T; Ratanasavanh D; Morel F; Gautier JC; Guillouzo A; Beaune P; Berthou F
    Chem Res Toxicol; 1993; 6(6):852-7. PubMed ID: 7509644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
    O'Shea D; Kim RB; Wilkinson GR
    Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes.
    Amet Y; Zerilli A; Goasduff T; Dréano Y; Berthou F
    Biochem Pharmacol; 1997 Oct; 54(8):947-52. PubMed ID: 9354595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
    Ernstgård L; Warholm M; Johanson G
    Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
    Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
    Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions.
    Hanioka N; Tanaka-Kagawa T; Miyata Y; Matsushima E; Makino Y; Ohno A; Yoda R; Jinno H; Ando M
    Xenobiotica; 2003 Jun; 33(6):575-86. PubMed ID: 12851035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.